Media Kit
Includes our Foundation Backgrounder, general information on Prostate Cancer, and much more.
Contact Us
For Additional Information send an email to press@pcf.org or call (310) 570-4722
Brand Identity
Approved logos and messaging.
Andrea K. Miyahira, PhD
BREAKING NEWS: FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
December 16, 2019 – Today the U.S. Food and Drug Administration (FDA) approved a new...
Winship study sheds light on immune control of cancer
Issued by: Emory University Woodruff Health Sciences Center New findings could provide doctors with vital...
Andrea K. Miyahira, PhD
BREAKING NEWS: FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
December 16, 2019 – Today the U.S. Food and Drug Administration (FDA) approved a new...
Winship study sheds light on immune control of cancer
Issued by: Emory University Woodruff Health Sciences Center New findings could provide doctors with vital...
The Prostate Cancer Foundation Adds Four New Centers Of Excellence To Serve And Honor Veterans With Prostate Cancer
LOS ANGELES, Calif., Nov. 11, 2019 /PRNewswire/ -- Four new Prostate Cancer Foundation (PCF) Centers of Excellence (COEs)...
THE PROSTATE CANCER FOUNDATION ANNOUNCES A COLLABORATIVE GRANTS PROGRAM IN PROSTATE CANCER RESEARCH
LOS ANGELES, Calif., September 26, 2019 – The Prostate Cancer Foundation (PCF) today announced a...
A Legacy of Leadership
Explore PCF's growth and impact over 25 years of funding the most promising prostate cancer research.
About our Work
Our goal is to put ourselves out of business, and we will not stop until not another man dies of prostate cancer.
Twitter Feed
Facebook Feed